CH644861A5 - Process for the preparation of 5-(2-furoyl)-, 5-(2-thenoyl)-, 5-(3-furoyl)- and 5-(3-thenoyl)-1,2-dihydro-3H-pyrrolo-[1,2-a]pyrrole-1-carboxylic acid derivatives - Google Patents

Process for the preparation of 5-(2-furoyl)-, 5-(2-thenoyl)-, 5-(3-furoyl)- and 5-(3-thenoyl)-1,2-dihydro-3H-pyrrolo-[1,2-a]pyrrole-1-carboxylic acid derivatives Download PDF

Info

Publication number
CH644861A5
CH644861A5 CH848877A CH848877A CH644861A5 CH 644861 A5 CH644861 A5 CH 644861A5 CH 848877 A CH848877 A CH 848877A CH 848877 A CH848877 A CH 848877A CH 644861 A5 CH644861 A5 CH 644861A5
Authority
CH
Switzerland
Prior art keywords
dihydro
pyrrolo
carboxylic acid
pyrrole
thenoyl
Prior art date
Application number
CH848877A
Other languages
German (de)
English (en)
Inventor
Joseph M Muchowski
Arthur F Kluge
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/771,283 external-priority patent/US4087539A/en
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of CH644861A5 publication Critical patent/CH644861A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
CH848877A 1976-07-14 1977-07-08 Process for the preparation of 5-(2-furoyl)-, 5-(2-thenoyl)-, 5-(3-furoyl)- and 5-(3-thenoyl)-1,2-dihydro-3H-pyrrolo-[1,2-a]pyrrole-1-carboxylic acid derivatives CH644861A5 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70485776A 1976-07-14 1976-07-14
US05/771,283 US4087539A (en) 1976-07-14 1977-02-23 5-(2-Furoyl)-, 5-(2-thenoyl)-, 5-(3-furoyl)- and 5-(3-thenoyl)-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof

Publications (1)

Publication Number Publication Date
CH644861A5 true CH644861A5 (en) 1984-08-31

Family

ID=27107392

Family Applications (2)

Application Number Title Priority Date Filing Date
CH4005/84A CH651045A5 (en) 1976-07-14 1977-07-08 Process for preparing 5-(2-furoyl)-,5-(2-thenoyl)-,5-(3-furoyl) and 5-(3-thenoyl)-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid esters
CH848877A CH644861A5 (en) 1976-07-14 1977-07-08 Process for the preparation of 5-(2-furoyl)-, 5-(2-thenoyl)-, 5-(3-furoyl)- and 5-(3-thenoyl)-1,2-dihydro-3H-pyrrolo-[1,2-a]pyrrole-1-carboxylic acid derivatives

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CH4005/84A CH651045A5 (en) 1976-07-14 1977-07-08 Process for preparing 5-(2-furoyl)-,5-(2-thenoyl)-,5-(3-furoyl) and 5-(3-thenoyl)-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid esters

Country Status (26)

Country Link
JP (1) JPS539789A (ja)
AR (1) AR218631A1 (ja)
AU (1) AU513385B2 (ja)
CA (1) CA1100140A (ja)
CH (2) CH651045A5 (ja)
CS (1) CS208724B2 (ja)
DE (1) DE2731662A1 (ja)
DK (1) DK152652C (ja)
ES (2) ES460705A1 (ja)
FI (1) FI63407C (ja)
FR (1) FR2361396A1 (ja)
GB (1) GB1554076A (ja)
GR (1) GR61607B (ja)
HK (1) HK17581A (ja)
IE (1) IE45302B1 (ja)
IL (1) IL52492A (ja)
IT (1) IT1117314B (ja)
MY (1) MY8100371A (ja)
NL (1) NL7707652A (ja)
NO (1) NO147563C (ja)
NZ (1) NZ184611A (ja)
PL (1) PL111408B1 (ja)
PT (1) PT66779B (ja)
SE (1) SE434644B (ja)
SU (2) SU664566A3 (ja)
YU (2) YU43156B (ja)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4097579A (en) * 1977-03-31 1978-06-27 Syntex (U.S.A.) Inc. 5-(2-Pyrroyl)-1,2-dihydro-3H-pyrrolo 1,2-a!pyrrole-1-carboxylic acid derivatives and process for the production thereof
US4140698A (en) * 1977-07-25 1979-02-20 Syntex (Usa) Inc. 1,2-Dihydro-3H-pyrrolo[1,2-a]pyrrole-1-nitriles
US4353829A (en) * 1980-11-21 1982-10-12 Syntex (U.S.A.) Inc. Process for 5-aroylation of 1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic esters
US4511724A (en) * 1982-06-10 1985-04-16 Merck & Co., Inc. 5-(Pyrrol-2-oyl)-1,2-dihydro-3H-pyrrolo [1,2-a]pyrrole derivatives as anti-inflammatory and analgesic agents
JPS5910589A (ja) * 1982-06-10 1984-01-20 メルク エンド カムパニー インコーポレーテツド 抗炎症剤および鎮痛剤として新規な5−(ピロ−ル−2−オイル)−1,2−ジヒドロ−3H−ピロロ〔1,2−a〕ピロ−ル誘導体
HU198927B (en) * 1987-01-14 1989-12-28 Richter Gedeon Vegyeszet Process for producing 1-/substituted aminomethyl/-octa-hydroindolo-(2,3-a)quinolizine derivatives, pharmaceutically applicable acid addition salts thereof, as well as pharmaceutical compositions comprising same
US4874871A (en) * 1987-03-25 1989-10-17 Syntex (U.S.A.) Inc. Process for preparing (+)-2,3-Dihydro-1H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid and related compounds

Also Published As

Publication number Publication date
PT66779A (fr) 1977-08-01
PT66779B (fr) 1978-12-18
SU664566A3 (ru) 1979-05-25
IE45302L (en) 1978-01-14
GB1554076A (en) 1979-10-17
JPS6254110B2 (ja) 1987-11-13
YU47683A (en) 1984-04-30
AU513385B2 (en) 1980-11-27
PL111408B1 (en) 1980-08-30
JPS539789A (en) 1978-01-28
AR218631A1 (es) 1980-06-30
YU43157B (en) 1989-04-30
IE45302B1 (en) 1982-07-28
CA1100140A (en) 1981-04-28
DK152652C (da) 1988-09-12
DK152652B (da) 1988-04-05
ES470213A1 (es) 1979-09-16
PL199602A1 (pl) 1979-01-29
DK307677A (da) 1978-01-15
DE2731662A1 (de) 1978-01-19
CH651045A5 (en) 1985-08-30
YU43156B (en) 1989-04-30
DE2731662C2 (ja) 1989-11-09
FR2361396B1 (ja) 1981-11-27
IL52492A0 (en) 1977-10-31
AU2697677A (en) 1979-01-18
CS208724B2 (en) 1981-09-15
NL7707652A (nl) 1978-01-17
YU47583A (en) 1984-06-30
ES460705A1 (es) 1979-10-01
FI63407B (fi) 1983-02-28
HK17581A (en) 1981-05-08
IL52492A (en) 1981-06-29
IT1117314B (it) 1986-02-17
NO772493L (no) 1978-01-17
FR2361396A1 (fr) 1978-03-10
GR61607B (en) 1978-12-02
FI63407C (fi) 1983-06-10
NO147563B (no) 1983-01-24
NO147563C (no) 1983-05-18
FI772154A (ja) 1978-01-15
SE7708142L (sv) 1978-01-15
SE434644B (sv) 1984-08-06
NZ184611A (en) 1979-03-28
MY8100371A (en) 1981-12-31
SU793400A3 (ru) 1980-12-30

Similar Documents

Publication Publication Date Title
DE2813373C2 (ja)
DE2503992A1 (de) Thyrosinderivate und diese verbindungen enthaltende arzneimittel
DD282690A5 (de) Verfahren zur herstellung von thienopyridinonen
DE2731678C2 (ja)
DD263772A5 (de) Verfahren zur herstellung neuer 1h, 3h-pyrrolo[1,2-c]thiazolderivate
DD259193A5 (de) Verfahren zur herstellung neuen thieno(2,3-b)-pyrrol-derivaten
DE2941869C2 (ja)
DE2727047A1 (de) Indol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische praeparate
CH504416A (de) Verfahren zur Herstellung von aromatischen Sulfamoylverbindungen
CH644861A5 (en) Process for the preparation of 5-(2-furoyl)-, 5-(2-thenoyl)-, 5-(3-furoyl)- and 5-(3-thenoyl)-1,2-dihydro-3H-pyrrolo-[1,2-a]pyrrole-1-carboxylic acid derivatives
DE2461802A1 (de) Pyrazinderivate
EP0005559B1 (de) Phenylaminothiophenessigsäuren, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE2106038C3 (de) 2-Imidazolin-2-ylamino-benzo [b] thiophene und diese enthaltende pharmazeutische Präparate
DE2807381A1 (de) Pharmazeutische zusammensetzung mit einem gehalt an einem 1,3,5-triazin- 2,6-dion
DE69110217T2 (de) Derivate der Kaffeinsäure und sie enthaltende pharmazeutische Zusammensetzungen.
AT364846B (de) Verfahren zur herstellung von neuen in stellung 5 substituierten 1,2-dihydro-3h-pyrrolo-(1,2-a) -pyrrol-1-carbonsaeuren und von deren einzelnen 1-saeureisomeren und d-saeureisomeren
AT390948B (de) Verfahren zur herstellung von neuen benzamid-derivaten
AT364845B (de) Verfahren zur herstellung von neuen in stellung 5 substituierten 1,2-dihydro-3h-pyrrolo-(1,2-a) -pyrrol-1-carbonsaeuren, von deren einzelnen 1-saeureisomeren und d-saeureisomeren und von deren pharmazeutisch unbedenklichen salzen
CH644862A5 (en) 5-(2- and 3-furoyl)- and 5-(2- and 3-thenoyl)-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acids and their salts and esters
AT369003B (de) Verfahren zur herstellung von neuen 5-aroyl-1,2dihydro-3h-pyrrolo(1,2-a)-pyrrol-1-carbons[ure
DE2854341C2 (ja)
DE1668137A1 (de) Verfahren zur Herstellung von neuen substituierten Zimtsaeuren
AT364844B (de) Verfahren zur herstellung von neuen 5-aroyl-1,2 -dihydro-3h-pyrrolo-(1,2-a)-pyrrol-1-carbonsaeuren und ihren salzen
DE3504678A1 (de) Neue imidazolyl-oxyalkansaeuren und -thioalkansaeuren, ihre derivate und verfahren zu ihrer herstellung
CH641461A5 (en) 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives

Legal Events

Date Code Title Description
PL Patent ceased